Non inasive prenatal testing: Difference between revisions
Jump to navigation
Jump to search
Cleaned text. Added a lot of missing links. This page needs some references. |
Added links to other wiki pages |
||
| Line 1: | Line 1: | ||
Non-invasive prenatal testing, NIPT, is a way of identifying [[ | Non-invasive prenatal testing, NIPT, is a way of identifying [[Chromosomal abnormalities|chromosomal abnormalities]] in unborn foetuses. It involves taking a sample of the mothers blood with will contain a small amount of cell free foetal [[DNA|DNA]] from the [[Placenta|placenta]], it is beneficial to invasive methods, such as [[Amniocentesis|amniocentesis]], because it doesn't have any associated risk of miscarriage. It can also be done early on in the pregnancy and can also be less expensive than other tests. | ||
The most common abnormalities that it detects are [[Aneuploidy|aneuploidies]] at [[ | The most common abnormalities that it detects are [[Aneuploidy|aneuploidies]] at [[Chromosome 21|chromosomes 21]] ([[Down Syndrome|Down Syndrome]]), [[Chromosome 18|18]] ([[Edward's Syndrome|Edward's Syndrome]]) and [[Chromosome 13|13]] ([[Patau Syndrome|Patau Syndrome]]). | ||
Latest revision as of 22:28, 5 December 2017
Non-invasive prenatal testing, NIPT, is a way of identifying chromosomal abnormalities in unborn foetuses. It involves taking a sample of the mothers blood with will contain a small amount of cell free foetal DNA from the placenta, it is beneficial to invasive methods, such as amniocentesis, because it doesn't have any associated risk of miscarriage. It can also be done early on in the pregnancy and can also be less expensive than other tests.
The most common abnormalities that it detects are aneuploidies at chromosomes 21 (Down Syndrome), 18 (Edward's Syndrome) and 13 (Patau Syndrome).